Press release
Surgery Partners, Inc. (NASDAQ: SGRY) Investor Investigation over potential Wrongdoing
An investigation on behalf of investors in Surgery Partners, Inc. (NASDAQ: SGRY) shares over potential wrongdoing.
Investors who purchased shares of Surgery Partners, Inc. (NASDAQ: SGRY) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Surgery Partners, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Surgery Partners, Inc. reported that its annual Total Revenue rose from over $1.34 billion in 2017 to over $1.77 billion in 2018 and that its Net Loss increased from $52.98 million in 2017 to $205.7 million in 2018.
Shares of Surgery Partners, Inc. (NASDAQ: SGRY) closed on January 24, 2020, at $18.07 per share.
Those who purchased shares of Surgery Partners, Inc. (NASDAQ: SGRY) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surgery Partners, Inc. (NASDAQ: SGRY) Investor Investigation over potential Wrongdoing here
News-ID: 2032114 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Surgery
Intraoperative Neuromonitoring Market Size to Hit Valuation of $4.90 Billion by …
IONM would improve intraoperative decision-making, by guiding a surgeons hands during surgery to reduce potential neurological risk. This benefits patients with a better surgical outcome and reduces a surgeons liability to a great extent.
Global Intraoperative Neuromonitoring (IONM) Market was valued at $3,036 million in 2015, and is projected to reach $4,900 million by 2022, growing at a CAGR of 7% from 2016 to 2022, according to a new report published…
Hemostats Market Research Insights by Major Applications Survey on cardiovascula …
Hemostasis is the course of blood clotting. Blood clotting plays a vital role in various surgeries by achieving positive outcomes with the reduction of blood loss. This clotting process reduces the surgery time and the need for blood transfusion.
Thus, hemostats are surgical instruments used to regulate the bleeding during surgery. Hemostats are also used for oozing out venomous bleeds, bone bleeding, and others. The scope of hemostats is growing rapidly…
Europe Data for Surgeries by Surgery Type (Hip Implant, Major Peritoneal Surgery …
The number of hip implant surgeries, major peritoneal surgeries, thoracic surgeries, and ENT surgeries along with the surgeries for central nervous system (CNS), in Europe were valued at 35,860 thousand procedures in 2016 and is projected to reach 41,818 thousand procedures by 2023. The study includes number of hip implants and major peritoneal, thoracic, CNS, and ENT surgeries performed in Europe. In addition, the report includes other relevant details for…
Surgical Robotics Market Growth Study by Component [Systems, Accessories and Ser …
Robotic surgery is a type of minimally invasive surgery which utilizes robotics for performing surgical procedures. These robotic systems are operated by surgeons and consists of miniaturized surgical instruments which are mounted on robotic arms, thus allowing surgeons to perform the surgeries precisely. The global surgical robotics market was valued at $56,294.9 million in 2017, and is expected to reach $98,737.0 million by 2024 at a CAGR of 8.5% during…
Ophthalmic Devices Market By Product Function [Ophthalmic Surgery Devices (Refra …
Ophthalmology is a branch of medical sciences that deals with the structure, function, and various eye diseases. The ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices gain increased importance and adoption due to high prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision related issues.
Request Sample At: https://www.bigmarketresearch.com/request-sample/1074435
Increase in prevalence rate of eye related diseases such as glaucoma, cataract,…
Global Microsurgery Market 2018: Application Segmented Into general surgery, oph …
Global microsurgery market is expected to reach USD 1,698.68 Million by 2025 from USD 1,003.63 Million in 2017, at a CAGR of 6.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
The major factors contributing to the growth of the market includes factors such as increasing prevalence…
